The Insulin Pens Market is undergoing a robust expansion, projected to reach $6.73 billion by 2031 at a CAGR of 6.7%. This growth trajectory is underpinned by factors such as the rising prevalence of diabetes, advances in insulin delivery technologies, and increasing patient preference for convenient drug administration methods. However, high costs, competition from alternative...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian